J&J's Application to Extend Patent on Anti-Tuberculosis Drug Bedaquiline Rejected
The patent would have extended J&J's monopoly on the anti-TB drug in India. But with this judgment, generic manufacturers can now make their own versions at an affordable price from this year.
New Delhi South Africa Phumeza Tisile Timesreported Latika Dawara Nandita Venkatesan Indian Patent Office On
Source: thewire.in